Cancer
ROCHESTER, Minn. — A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment,[...]
Latest stories
Research
February 26, 2026
Biotherapeutics
February 25, 2026
Neurosciences
February 23, 2026
Cancer
February 19, 2026
Cancer
February 16, 2026
AI and Digital Health
February 16, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community